BioLabs@NYU Langone Relocates to Innolabs in Long Island City
King Street Properties and development partner GFP Real Estate, in collaboration with NYU Langone Health, have announced that BioLabs@NYU Langone—an incubator dedicated to nurturing early-stage biotechnology companies—will relocate from Manhattan to Long Island City.
BioLabs has signed a lease for 46,000 square feet at Innolabs, a state-of-the-art life sciences facility located in Long Island City.
“We are proud to support NYU Langone and BioLabs in their mission to nurture groundbreaking companies at the earliest stages, providing an unmatched quality of space and services,” said Ed Jaram of King Street Properties. “This addition reinforces Innolabs as the destination in NYC for top-tier life sciences companies. The combination of NYU Langone’s status as a leading academic medical institution and BioLabs’ excellence in supporting early-stage companies is a clear signal of the next chapter for life sciences in New York City.”
Innolabs is a 267,000-square-foot Class A property tailored to meet the needs of innovative life science companies and institutions. Headquartered in Boston, BioLabs operates the largest global network of co-working laboratory facilities, with locations in 17 metropolitan markets across the United States, Europe, and Japan. Its network includes partnerships with well-known entities such as LabCentral and MBC-BioLabs.
